"PUBLICATION_YEAR","PMID","ISSN-Electronic","ISSN-Linking","ISO-ABBREVIATION","JOURNAL-TITLE","ARTICLE-TITLE","DOI","IMPACT_FACTOR_2017","IMPACT_FACTOR_2016","IMPACT_FACTOR_2015","ALTMETRIC","DIMENSION_CITATIONS","DIMENSION_RECENT_CITATIONS","DIMENSION_FIELD_CITATION_RATIO","DIMENSION_RELATIVE_CITATION_RATIO","ITALY","FISM","AGENDA","IMPACT_FACTOR_2018","Affiliazione"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"Vita-Salute San Raffaele University"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"Vita-Salute San Raffaele University"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"Vita-Salute San Raffaele University"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"Vita-Salute San Raffaele University"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31138656,"1529-2401","0270-6474","J. Neurosci.","The Journal of neuroscience : the official journal of the Society for Neuroscience","Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.","10.1523/JNEUROSCI.0227-18.2019","no_if_2017_found",,"no_if_2015_found",8,4,4,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,30351211,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","The Multiple Sclerosis Care Unit.","10.1177/1352458518807082","no_if_2017_found",,"no_if_2015_found",4,10,10,,,"Y","Y","no_agenda",,"Queen Mary University of London"
2019,30351211,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","The Multiple Sclerosis Care Unit.","10.1177/1352458518807082","no_if_2017_found",,"no_if_2015_found",4,10,10,,,"Y","Y","no_agenda",,"Hospital Universitari Vall d'Hebron"
2019,30351211,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","The Multiple Sclerosis Care Unit.","10.1177/1352458518807082","no_if_2017_found",,"no_if_2015_found",4,10,10,,,"Y","Y","no_agenda",,"Danish Multiple Sclerosis Center"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"Fondazione Santa Lucia"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"Institute Experimental Endocrinology and Oncology"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"Imperial College London"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30815035,"1756-2856","1756-2856","Ther Adv Neurol Disord","Therapeutic advances in neurological disorders","Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis.","10.1177/1756286418819074","4.75",4.192,"2.642",1,4,4,,,"Y","Y","no_agenda",3.58,"University of Naples Federico II"
2019,30531078,"1673-5374","1673-5374","Neural Regen Res","Neural regeneration research","Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis.","10.4103/1673-5374.243707","2.234",1.769,"0.968",1,1,1,,,"Y","Y","no_agenda",2.472,"University of Perugia"
2019,30531078,"1673-5374","1673-5374","Neural Regen Res","Neural regeneration research","Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis.","10.4103/1673-5374.243707","2.234",1.769,"0.968",1,1,1,,,"Y","Y","no_agenda",2.472,"University of Perugia"
2019,30531078,"1673-5374","1673-5374","Neural Regen Res","Neural regeneration research","Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis.","10.4103/1673-5374.243707","2.234",1.769,"0.968",1,1,1,,,"Y","Y","no_agenda",2.472,"University of Perugia"
2019,30531078,"1673-5374","1673-5374","Neural Regen Res","Neural regeneration research","Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis.","10.4103/1673-5374.243707","2.234",1.769,"0.968",1,1,1,,,"Y","Y","no_agenda",2.472,"University of Perugia"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Carlo Besta Neurological Institute"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Turin"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Carlo Besta Neurological Institute"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Istituti di Ricovero e Cura a Carattere Scientifico"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Turin"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Chieti-Pescara"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Chieti-Pescara"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Turin"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Istituti di Ricovero e Cura a Carattere Scientifico"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Carlo Besta Neurological Institute"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Turin"
2019,29761738,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.","10.1177/1352458518774935","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Turin"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"San Raffaele Hospital"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"San Raffaele Hospital"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"San Raffaele Hospital"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"San Raffaele Hospital"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"University of Rome Tor Vergata"
2019,31431121,"1552-6844","1545-9683","Neurorehabil Neural Repair","Neurorehabilitation and neural repair","Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis.","10.1177/1545968319868713","4.711",4.107,"4.035",9,2,2,,,"Y","Y","no_agenda",3.757,"Istituto Neurologico Mediterraneo"
2019,31578295,"1098-5514","0022-538X","J. Virol.","Journal of virology","Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.","10.1128/JVI.00980-19","4.368",4.663,"4.606",20,2,2,,,"Y","Y","progressive",4.324,"National Institute of Health"
2019,31578295,"1098-5514","0022-538X","J. Virol.","Journal of virology","Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.","10.1128/JVI.00980-19","4.368",4.663,"4.606",20,2,2,,,"Y","Y","progressive",4.324,"Azienda Ospedaliera Citta' Della Salute E Della Scienza Di Torino"
2019,31578295,"1098-5514","0022-538X","J. Virol.","Journal of virology","Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.","10.1128/JVI.00980-19","4.368",4.663,"4.606",20,2,2,,,"Y","Y","progressive",4.324,"National Institute of Health"
2019,31578295,"1098-5514","0022-538X","J. Virol.","Journal of virology","Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.","10.1128/JVI.00980-19","4.368",4.663,"4.606",20,2,2,,,"Y","Y","progressive",4.324,"National Institute of Health"
2019,31578295,"1098-5514","0022-538X","J. Virol.","Journal of virology","Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.","10.1128/JVI.00980-19","4.368",4.663,"4.606",20,2,2,,,"Y","Y","progressive",4.324,"National Institute of Health"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31454778,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS.","10.1212/NXI.0000000000000596","no_if_2017_found",,"no_if_2015_found",9,4,4,,,"Y","Y","progressive",,"University of Genoa"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"Italian Institute for Auxology"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"Italian Institute for Auxology"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"Italian Institute for Auxology"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"University of Turin"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"Italian Institute for Auxology"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"University of Turin"
2019,31498137,"1878-6448","1053-8135","NeuroRehabilitation","NeuroRehabilitation","Constraint-Induced Movement Therapy in multiple sclerosis: Safety and three-dimensional kinematic analysis of upper limb activity. A randomized single-blind pilot study.","10.3233/NRE-192762","1.779",1.495,"1.453",5,2,2,,,"Y","Y","progressive",1.197,"University of Eastern Piedmont Amadeo Avogadro"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"University of Milan"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31237799,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.","10.1177/1352458519852092","no_if_2017_found",,"no_if_2015_found",3,3,3,,,"Y","Y","no_agenda",,"Washington University in St. Louis"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Campania Luigi Vanvitelli"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Azienda Ospedaliero-Universitaria Careggi"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Magna Graecia University"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Campania Luigi Vanvitelli"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Carlo Besta Neurological Institute"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Naples Federico II"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Cagliari"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Parma"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Naples Federico II"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Cagliari"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Cagliari"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Campania Luigi Vanvitelli"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Ospedale regionale di Lugano"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Parma"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Naples Federico II"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Cagliari"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Azienda Ospedaliero-Universitaria Careggi"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Ospedale regionale di Lugano"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Rome Tor Vergata"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Azienda Ospedaliero-Universitaria Careggi"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Naples Federico II"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Florence"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Palermo"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Azienda Ospedaliero-Universitaria Careggi"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Ospedale regionale di Lugano"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Palermo"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Campania Luigi Vanvitelli"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Genoa"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"Ospedale regionale di Lugano"
2019,31573386,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.","10.1177/1352458519872889","no_if_2017_found",,"no_if_2015_found",18,1,1,,,"Y","Y","progressive",,"University of Italian Switzerland"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31687212,"2090-2654","2090-2654","Mult Scler Int","Multiple sclerosis international","Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis.","10.1155/2019/9149201","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Fondazione Santa Lucia"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"National Research Council"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"University of Rome Tor Vergata"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Fondazione Santa Lucia"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"National Research Council"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"National Research Council"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"University of Naples Federico II"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"University of Naples Federico II"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31161863,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Obesity worsens central inflammation and disability in multiple sclerosis.","10.1177/1352458519853473","no_if_2017_found",,"no_if_2015_found",116,8,8,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,29658343,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Older age, higher perceived disability and depressive symptoms predict the amount and severity of work-related difficulties in persons with multiple sclerosis.","10.1080/09638288.2018.1461937","2.042",1.804,"1.919",7,2,2,,,"Y","Y","no_agenda",2.054,"Carlo Besta Neurological Institute"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,31086807,"2332-7812","2332-7812","Neurol Neuroimmunol Neuroinflamm","Neurology(R) neuroimmunology & neuroinflammation","Different MRI patterns in MS worsening after stopping fingolimod.","10.1212/NXI.0000000000000566","no_if_2017_found",,"no_if_2015_found",4,4,4,,,"Y","Y","no_agenda",,"University of Genoa"
2019,30192317,"1533-4287","1064-8011","J Strength Cond Res","Journal of strength and conditioning research","Meta-analytic and Scoping Study on Strength Training in People With Multiple Sclerosis.","10.1519/JSC.0000000000002381","2.325",2.06,"no_if_2015_found",10,0,0,,,"Y","Y","no_agenda",3.017,"University of Sassari"
2019,30192317,"1533-4287","1064-8011","J Strength Cond Res","Journal of strength and conditioning research","Meta-analytic and Scoping Study on Strength Training in People With Multiple Sclerosis.","10.1519/JSC.0000000000002381","2.325",2.06,"no_if_2015_found",10,0,0,,,"Y","Y","no_agenda",3.017,"Tel Aviv University"
2019,30192317,"1533-4287","1064-8011","J Strength Cond Res","Journal of strength and conditioning research","Meta-analytic and Scoping Study on Strength Training in People With Multiple Sclerosis.","10.1519/JSC.0000000000002381","2.325",2.06,"no_if_2015_found",10,0,0,,,"Y","Y","no_agenda",3.017,"University of Sassari"
2019,29683371,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Hippocampal-related memory network in multiple sclerosis: A structural connectivity analysis.","10.1177/1352458518771838","no_if_2017_found",,"no_if_2015_found",2,2,2,,,"Y","Y","no_agenda",,"University of Barcelona"
2019,30964396,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.","10.1177/1352458519832259","no_if_2017_found",,"no_if_2015_found",47,11,11,,,"Y","Y","progressive",,"University of Brescia"
2019,30964396,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.","10.1177/1352458519832259","no_if_2017_found",,"no_if_2015_found",47,11,11,,,"Y","Y","progressive",,"Spedali Civili di Brescia"
2019,30964396,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.","10.1177/1352458519832259","no_if_2017_found",,"no_if_2015_found",47,11,11,,,"Y","Y","progressive",,"San Raffaele Hospital"
2019,30964396,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.","10.1177/1352458519832259","no_if_2017_found",,"no_if_2015_found",47,11,11,,,"Y","Y","progressive",,"Spedali Civili di Brescia"
2019,30964396,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy.","10.1177/1352458519832259","no_if_2017_found",,"no_if_2015_found",47,11,11,,,"Y","Y","progressive",,"Spedali Civili di Brescia"
2019,31502913,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.","10.1177/1352458519857075","no_if_2017_found",,"no_if_2015_found",1,0,0,,,"Y","Y","personalized_medicine",,"Associazione Italiana Sclerosi Multipla"
2019,31502913,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.","10.1177/1352458519857075","no_if_2017_found",,"no_if_2015_found",1,0,0,,,"Y","Y","personalized_medicine",,"Associazione Italiana Sclerosi Multipla"
2019,31502913,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.","10.1177/1352458519857075","no_if_2017_found",,"no_if_2015_found",1,0,0,,,"Y","Y","personalized_medicine",,"Associazione Italiana Sclerosi Multipla"
2019,31502913,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond center-based testing: Understanding and improving functioning with wearable technology in MS.","10.1177/1352458519857075","no_if_2017_found",,"no_if_2015_found",1,0,0,,,"Y","Y","personalized_medicine",,"Associazione Italiana Sclerosi Multipla"
2019,31469359,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS.","10.1177/1352458519846096","no_if_2017_found",,"no_if_2015_found",16,2,2,,,"Y","Y","no_agenda",,"University of Perugia"
2019,31469359,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS.","10.1177/1352458519846096","no_if_2017_found",,"no_if_2015_found",16,2,2,,,"Y","Y","no_agenda",,"Ospedale San Camillo"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"University of Ferrara"
2019,30689576,"1875-8908","1387-2877","J. Alzheimers Dis.","Journal of Alzheimer's disease : JAD","KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.","10.3233/JAD-180777","no_if_2017_found",,"no_if_2015_found",10,8,8,,,"Y","Y","progressive",,"Arcispedale Sant'Anna"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Catholic University of the Sacred Heart"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Italian Institute for Auxology"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Catholic University of the Sacred Heart"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Catholic University of the Sacred Heart"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Italian Institute for Auxology"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Catholic University of the Sacred Heart"
2019,29485319,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Online meditation training for people with multiple sclerosis: A randomized controlled trial.","10.1177/1352458518761187","no_if_2017_found",,"no_if_2015_found",7,8,8,,,"Y","Y","no_agenda",,"Harvard University"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitari Vall d'Hebron"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"John Hunter Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitari Vall d'Hebron"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitari Vall d'Hebron"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Centre for Genomic Regulation"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitari Vall d'Hebron"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Columbia University Medical Center"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"San Raffaele Hospital"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Centre for Genomic Regulation"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitario Ramón y Cajal"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Columbia University Medical Center"
2019,31221001,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","NINJ2 in the response to Interferon-β in multiple sclerosis.","10.1177/1352458519851428","no_if_2017_found",,"no_if_2015_found",2,0,0,,,"Y","Y","no_agenda",,"Hospital Universitario Ramón y Cajal"
2019,30678613,"1875-533X","0929-8673","Curr. Med. Chem.","Current medicinal chemistry","Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone.","10.2174/0929867326666190124122752","3.469",3.249,"3.455",,1,1,,,"Y","Y","no_agenda",3.894,"Open University"
2019,30678613,"1875-533X","0929-8673","Curr. Med. Chem.","Current medicinal chemistry","Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone.","10.2174/0929867326666190124122752","3.469",3.249,"3.455",,1,1,,,"Y","Y","no_agenda",3.894,"Open University"
2019,30678613,"1875-533X","0929-8673","Curr. Med. Chem.","Current medicinal chemistry","Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: the Case of Edaravone.","10.2174/0929867326666190124122752","3.469",3.249,"3.455",,1,1,,,"Y","Y","no_agenda",3.894,"National Institute of Health"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Florence"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Milan"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Chieti-Pescara"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Milan"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"San Raffaele Hospital"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"Ospedale San Camillo"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"San Raffaele Hospital"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Chieti-Pescara"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"Ospedale San Camillo"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Bari Aldo Moro"
2019,31056979,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.","10.1080/09638288.2019.1610511","2.042",1.804,"1.919",1,1,1,,,"Y","Y","no_agenda",2.054,"University of Bari Aldo Moro"
2019,31250663,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Perspectives on neurorehabilitation of unilateral impairments through cross-education.","10.1080/09638288.2019.1635656","2.042",1.804,"1.919",,0,0,,,"Y","Y","no_agenda",2.054,"University of Sassari"
2019,31250663,"1464-5165","0963-8288","Disabil Rehabil","Disability and rehabilitation","Perspectives on neurorehabilitation of unilateral impairments through cross-education.","10.1080/09638288.2019.1635656","2.042",1.804,"1.919",,0,0,,,"Y","Y","no_agenda",2.054,"University of Sassari"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"Istituto Neurologico Mediterraneo"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"University of Rome Tor Vergata"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"Istituto Neurologico Mediterraneo"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"Istituto Neurologico Mediterraneo"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"University of Rome Tor Vergata"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"Istituto Neurologico Mediterraneo"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"San Raffaele Hospital"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"University of Rome Tor Vergata"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"University of Rome Tor Vergata"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"San Raffaele Hospital"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"San Raffaele Hospital"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"University of Rome Tor Vergata"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"San Raffaele Hospital"
2019,31100354,"1095-953X","0969-9961","Neurobiol. Dis.","Neurobiology of disease","Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.","10.1016/J.NBD.2019.05.010","5.227",5.02,"4.856",,6,6,,,"Y","Y","no_agenda",5.16,"Fondazione Santa Lucia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"Istituto Nazionale per le Ricerche Cardiovascolari"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Ferrara"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"Villa Maria Cecilia Hospital"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Ferrara"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"Villa Maria Cecilia Hospital"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31373677,"1521-4141","0014-2980","Eur. J. Immunol.","European journal of immunology","Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients.","10.1002/EJI.201948223","4.248",4.227,"no_if_2015_found",2,2,2,,,"Y","Y","progressive",4.695,"University of Modena and Reggio Emilia"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Chieti-Pescara"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Campania Luigi Vanvitelli"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Turin"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Carlo Besta Neurological Institute"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Parma"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Campania Luigi Vanvitelli"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Cagliari"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Cagliari"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Parma"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Rome Tor Vergata"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Naples Federico II"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Rome Tor Vergata"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Palermo"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Azienda Ospedaliero-Universitaria Careggi"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Ca' Foncello Hospital"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Azienda Ospedaliero-Universitaria Careggi"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Ca' Foncello Hospital"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"Carlo Besta Neurological Institute"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Cagliari"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Campania Luigi Vanvitelli"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Chieti-Pescara"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Genoa"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Naples Federico II"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Palermo"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Parma"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Rome Tor Vergata"
2019,31610404,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.","10.1016/J.MSARD.2019.101430","3.199",2.349,"1.15",2,2,2,,,"Y","Y","no_agenda",2.725,"University of Turin"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Istituto Neurologico Mediterraneo"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"University of Pavia"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"University of Pavia"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Fondazione Santa Lucia"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Fondazione Santa Lucia"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Istituto Neurologico Mediterraneo"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Don Carlo Gnocchi Foundation"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"Don Carlo Gnocchi Foundation"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"University of Pavia"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"University of Verona"
2019,30809137,"1662-5161","1662-5161","Front Hum Neurosci","Frontiers in human neuroscience","The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.","10.3389/FNHUM.2019.00031","2.871",3.209,"3.634",2,4,4,,,"Y","Y","pediatric",2.87,"University of Pavia"
2019,31536728,"1090-2430","0014-4886","Exp. Neurol.","Experimental neurology","Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.","10.1016/J.EXPNEUROL.2019.113065","4.483",4.706,"4.657",11,1,1,,,"Y","Y","progressive",4.562,"University of Florence"
2019,31536728,"1090-2430","0014-4886","Exp. Neurol.","Experimental neurology","Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.","10.1016/J.EXPNEUROL.2019.113065","4.483",4.706,"4.657",11,1,1,,,"Y","Y","progressive",4.562,"University of Florence"
2019,31536728,"1090-2430","0014-4886","Exp. Neurol.","Experimental neurology","Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.","10.1016/J.EXPNEUROL.2019.113065","4.483",4.706,"4.657",11,1,1,,,"Y","Y","progressive",4.562,"University of Florence"
2019,31536728,"1090-2430","0014-4886","Exp. Neurol.","Experimental neurology","Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.","10.1016/J.EXPNEUROL.2019.113065","4.483",4.706,"4.657",11,1,1,,,"Y","Y","progressive",4.562,"University of Florence"
2019,31536728,"1090-2430","0014-4886","Exp. Neurol.","Experimental neurology","Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.","10.1016/J.EXPNEUROL.2019.113065","4.483",4.706,"4.657",11,1,1,,,"Y","Y","progressive",4.562,"University of Florence"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Fondazione Santa Lucia"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Fondazione Santa Lucia"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Ospedale San Camillo"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Ospedale San Camillo"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Fondazione Santa Lucia"
2019,31181776,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.","10.3390/IJMS20112811","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"Fondazione Santa Lucia"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Catania"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University Medical Center Hamburg-Eppendorf"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Campania Luigi Vanvitelli"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Associazione Italiana Sclerosi Multipla"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituto Neurologico Mediterraneo"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Rome Tor Vergata"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Marche Polytechnic University"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Carlo Besta Neurological Institute"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Marche Polytechnic University"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituto Neurologico Mediterraneo"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Modena and Reggio Emilia"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Verona"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Campania Luigi Vanvitelli"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Carlo Besta Neurological Institute"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Turin"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Carlo Besta Neurological Institute"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Parma"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University Medical Center Hamburg-Eppendorf"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Naples Federico II"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituto delle Scienze Neurologiche di Bologna"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Bologna"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Bari Aldo Moro"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituti di Ricovero e Cura a Carattere Scientifico"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Catania"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Chieti-Pescara"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Ospedale San Camillo"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University Medical Center Hamburg-Eppendorf"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituto delle Scienze Neurologiche di Bologna"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Istituto Neurologico Mediterraneo"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University Medical Center Hamburg-Eppendorf"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Carlo Besta Neurological Institute"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Associazione Italiana Sclerosi Multipla"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Carlo Besta Neurological Institute"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"Ospedale San Camillo"
2019,31507519,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.","10.3389/FNEUR.2019.00916","3.508",3.552,"3.184",2,1,1,,,"Y","Y","progressive",2.635,"University of Parma"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Tel Aviv University"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31100700,"1879-1271","0268-0033","Clin Biomech (Bristol, Avon)","Clinical biomechanics (Bristol, Avon)","Isokinetic predictors of gait speed increase following high-intensity resistance training of the ankle dorsiflexors in people with multiple sclerosis: A pilot study.","10.1016/J.CLINBIOMECH.2019.05.008","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Sassari"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Siena"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Florence"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Florence"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Siena"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Siena"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"European Institute of Oncology"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"European Institute of Oncology"
2019,31134091,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells.","10.3389/FIMMU.2019.01041","5.511",6.429,"5.695",2,0,0,,,"Y","Y","no_agenda",4.716,"University of Siena"
2019,30291467,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.","10.1007/S10072-018-3589-6","no_if_2017_found",,"no_if_2015_found",6,7,7,,,"Y","Y","no_agenda",,"University of Siena"
2019,30291467,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.","10.1007/S10072-018-3589-6","no_if_2017_found",,"no_if_2015_found",6,7,7,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30291467,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.","10.1007/S10072-018-3589-6","no_if_2017_found",,"no_if_2015_found",6,7,7,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30291467,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.","10.1007/S10072-018-3589-6","no_if_2017_found",,"no_if_2015_found",6,7,7,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30291467,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical, and quality of life aspects.","10.1007/S10072-018-3589-6","no_if_2017_found",,"no_if_2015_found",6,7,7,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Florence"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Foggia"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Campania Luigi Vanvitelli"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Naples Federico II"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Cagliari"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"San Raffaele Hospital"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Istituto Neurologico Mediterraneo"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Sapienza University of Rome"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Ospedale Vito Fazzi"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Ospedale San Camillo"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Bari Aldo Moro"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Bari Aldo Moro"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Campania Luigi Vanvitelli"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Ospedale Garibaldi"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Ospedale Antonio Cardarelli"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Bari Aldo Moro"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Rome Tor Vergata"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Bari Aldo Moro"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Catania"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Sapienza University of Rome"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Palermo"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Istituto Neurologico Mediterraneo"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"Sapienza University of Rome"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"San Salvatore Hospital"
2019,31535270,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.","10.1007/S00415-019-09531-6","3.783",3.389,"3.408",,0,0,,,"Y","Y","no_agenda",4.204,"University of Bari Aldo Moro"
2019,31796805,"2045-2322","2045-2322","Sci Rep","Scientific reports","Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.","10.1038/S41598-019-54595-Z","4.122",4.259,"5.228",10,1,1,,,"Y","Y","no_agenda",4.011,"KU Leuven"
2019,31796805,"2045-2322","2045-2322","Sci Rep","Scientific reports","Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.","10.1038/S41598-019-54595-Z","4.122",4.259,"5.228",10,1,1,,,"Y","Y","no_agenda",4.011,"Marche Polytechnic University"
2019,31796805,"2045-2322","2045-2322","Sci Rep","Scientific reports","Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.","10.1038/S41598-019-54595-Z","4.122",4.259,"5.228",10,1,1,,,"Y","Y","no_agenda",4.011,"San Raffaele Hospital"
2019,31796805,"2045-2322","2045-2322","Sci Rep","Scientific reports","Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.","10.1038/S41598-019-54595-Z","4.122",4.259,"5.228",10,1,1,,,"Y","Y","no_agenda",4.011,"Italian Medicines Agency"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"INFN Sezione di Bari"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"INFN Sezione di Bari"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"National Research Council"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"University of Bari Aldo Moro"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"National Research Council"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"National Research Council"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"University of Bari Aldo Moro"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"INFN Sezione di Bari"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"University of Bari Aldo Moro"
2019,30656857,"2162-3279","no_issn_linking","Brain Behav","Brain and behavior","Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study.","10.1002/BRB3.1199","2.219",2.157,"2.128",,3,3,,,"Y","Y","pediatric",2.072,"University of Bari Aldo Moro"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"Associazione Italiana Sclerosi Multipla"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"University of Siena"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"University of Genoa"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"University of Genoa"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"Associazione Italiana Sclerosi Multipla"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"University of Genoa"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"Associazione Italiana Sclerosi Multipla"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"University of Genoa"
2019,31085282,"1873-7544","0306-4522","Neuroscience","Neuroscience","Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis.","10.1016/J.NEUROSCIENCE.2019.05.004","3.382",3.277,"3.231",,1,1,,,"Y","Y","no_agenda",3.244,"Associazione Italiana Sclerosi Multipla"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas Research Hospital"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas University"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Washington University in St. Louis"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas University"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas Research Hospital"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas University"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas University"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Washington University in St. Louis"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas Research Hospital"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas University"
2019,30566690,"1460-2083","0964-6906","Hum. Mol. Genet.","Human molecular genetics","Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.","10.1093/HMG/DDY438","4.902",5.34,"5.985",,8,8,3.09,,"Y","Y","no_agenda",4.544,"Humanitas Research Hospital"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Associazione Italiana Sclerosi Multipla"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Siena"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Karolinska Institute"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Instituto de Investigación Biomédica de Málaga"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Ottawa Hospital"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Genoa"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Imperial College London"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Royan Institute"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Rigshospitalet"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"Paracelsus Medical University"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Copenhagen"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Genoa"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Genoa"
2019,31072380,"1745-6215","1745-6215","Trials","Trials","MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.","10.1186/S13063-019-3346-Z","2.067",1.969,"1.859",,9,9,,,"Y","Y","data_sharing",1.975,"University of Basel"
2019,30847559,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.","10.1007/S00401-019-01980-7","15.872",12.213,"11.36",5,23,23,,,"N","Y","no_agenda",18.174,"University of Miami"
2019,30847559,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.","10.1007/S00401-019-01980-7","15.872",12.213,"11.36",5,23,23,,,"N","Y","no_agenda",18.174,"University of Southern Denmark"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"University of Florence"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"University of Siena"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Vita-Salute San Raffaele University"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Mario Negri Institute for Pharmacological Research"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"University of Cagliari"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Mario Negri Institute for Pharmacological Research"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"University of Catania"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"University of Bari Aldo Moro"
2019,30426289,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","The Italian multiple sclerosis register.","10.1007/S10072-018-3610-0","no_if_2017_found",,"no_if_2015_found",1,12,12,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"National Institute of Health"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Swansea University"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"University of Verona"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Great Ormond Street Hospital"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"Imperial College London"
2019,31810488,"1742-2094","1742-2094","J Neuroinflammation","Journal of neuroinflammation","Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.","10.1186/S12974-019-1650-X","5.193",5.102,"4.667",1,1,1,,,"Y","Y","progressive",5.7,"University of Manchester"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University of Siena"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Carlo Besta Neurological Institute"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Carlo Besta Neurological Institute"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University of Lübeck"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Medical University of Sofia"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Barzilai Medical Center"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Ben-Gurion University of the Negev"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Hospital Universitari Vall d'Hebron"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University of Kent"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University of Belgrade"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University Medical Center Hamburg-Eppendorf"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Hospital Universitari Vall d'Hebron"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"Carlo Besta Neurological Institute"
2019,30035845,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.","10.1111/ENE.13760","4.621",3.988,"3.956",11,5,5,,,"Y","Y","no_agenda",4.387,"University Hospital Cologne"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"Home for Relief of the Suffering"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"University of Eastern Piedmont Amadeo Avogadro"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"Home for Relief of the Suffering"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"University of Eastern Piedmont Amadeo Avogadro"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"Home for Relief of the Suffering"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"University of Eastern Piedmont Amadeo Avogadro"
2019,31456737,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity.","10.3389/FNEUR.2019.00866","3.508",3.552,"3.184",19,2,2,,,"Y","Y","no_agenda",2.635,"Azienda Ospedaliero Universitaria Maggiore della Carita"
2019,31110181,"2041-1723","2041-1723","Nat Commun","Nature communications","A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.","10.1038/S41467-019-09773-Y","12.353",12.124,"11.329",36,11,11,,,"N","Y","no_agenda",11.878,"University of California, San Francisco"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Milan"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Milan"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Turin"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"San Raffaele Hospital"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Milan"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Neuroscience Institute"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Humanitas University"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Milan"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Genoa"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Humanitas Research Hospital"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Neuroscience Institute"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Turin"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Neuroscience Institute"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Genoa"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"Neuroscience Institute"
2019,31363836,"1432-0533","0001-6322","Acta Neuropathol.","Acta neuropathologica","Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.","10.1007/S00401-019-02049-1","15.872",12.213,"11.36",23,7,7,,,"Y","Y","no_agenda",18.174,"University of Milan"
2019,31878257,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.","10.3390/IJMS21010143","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"University of Rome Tor Vergata"
2019,31878257,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.","10.3390/IJMS21010143","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"University of Rome Tor Vergata"
2019,31878257,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.","10.3390/IJMS21010143","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"San Raffaele University of Rome"
2019,31878257,"1422-0067","1422-0067","Int J Mol Sci","International journal of molecular sciences","Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity.","10.3390/IJMS21010143","3.687",3.226,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",4.183,"San Raffaele University of Rome"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"National Institute of Health"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Medical University of Vienna"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Medical University of Vienna"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Imperial College London"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Imperial College London"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Imperial College London"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"National Institute of Health"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"University of Verona"
2019,31675181,"2328-9503","2328-9503","Ann Clin Transl Neurol","Annals of clinical and translational neurology","Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.","10.1002/ACN3.50893","4.649",3.901,"no_if_2015_found",8,1,1,,,"Y","Y","no_agenda",4.656,"Merck Serono"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Sapienza University of Rome"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"San Raffaele Hospital"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Sapienza University of Rome"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"San Raffaele Hospital"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Monash University"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Sapienza University of Rome"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Istituto Neurologico Mediterraneo"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Sapienza University of Rome"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"National Institute of Health"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"San Raffaele Hospital"
2019,31047767,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.","10.1016/J.JAUT.2019.04.006","7.607",7.641,"7.76",33,2,2,,,"Y","Y","no_agenda",7.543,"Sapienza University of Rome"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"Lawrence Berkeley National Laboratory"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, Berkeley"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"Loma Linda University"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, Riverside"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, Riverside"
2019,31010726,"1095-9157","0896-8411","J. Autoimmun.","Journal of autoimmunity","Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.","10.1016/J.JAUT.2019.04.003","7.607",7.641,"7.76",10,1,1,,,"N","Y","progressive",7.543,"University of California, San Francisco"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Associazione Italiana Sclerosi Multipla"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"AZ Klina"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Tel Aviv University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"AZ Klina"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Sheba Medical Center"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31835502,"2077-0383","2077-0383","J Clin Med","Journal of clinical medicine","Structured Cognitive-Motor Dual Task Training Compared to Single Mobility Training in Persons with Multiple Sclerosis, a Multicenter RCT.","10.3390/JCM8122177","5.583",,"no_if_2015_found",3,1,1,,,"Y","Y","no_agenda",5.688,"Hasselt University"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Istituto Neurologico Mediterraneo"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"University of Rome Tor Vergata"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Istituto Neurologico Mediterraneo"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Istituto Neurologico Mediterraneo"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"University of Rome Tor Vergata"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Istituto Neurologico Mediterraneo"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"University of Rome Tor Vergata"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"University of Rome Tor Vergata"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Vita-Salute San Raffaele University"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"Vita-Salute San Raffaele University"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"University of Rome Tor Vergata"
2019,31572399,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.","10.3389/FIMMU.2019.02197","5.511",6.429,"5.695",1,3,3,,,"Y","Y","no_agenda",4.716,"San Raffaele Hospital"
2019,30710887,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.","10.1016/J.MSARD.2019.01.043","3.199",2.349,"1.15",,6,6,,,"Y","Y","progressive",2.725,"Sapienza University of Rome"
2019,30710887,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.","10.1016/J.MSARD.2019.01.043","3.199",2.349,"1.15",,6,6,,,"Y","Y","progressive",2.725,"Don Carlo Gnocchi Foundation"
2019,30710887,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.","10.1016/J.MSARD.2019.01.043","3.199",2.349,"1.15",,6,6,,,"Y","Y","progressive",2.725,"Don Carlo Gnocchi Foundation"
2019,30710887,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.","10.1016/J.MSARD.2019.01.043","3.199",2.349,"1.15",,6,6,,,"Y","Y","progressive",2.725,"Ospedale San Camillo"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Sapienza University of Rome"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Ospedale San Camillo"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Sapienza University of Rome"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Ospedale San Camillo"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Ospedale San Camillo"
2019,31212712,"2073-4409","2073-4409","Cells","Cells","CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis.","10.3390/CELLS8060575","4.829",,"no_if_2015_found",,2,2,,,"Y","Y","no_agenda",5.656,"Sapienza University of Rome"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Florence"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Milan"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Chieti-Pescara"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Milan"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"San Raffaele Hospital"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"Ospedale San Camillo"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"San Raffaele Hospital"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Milan"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Florence"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Chieti-Pescara"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"Ospedale San Camillo"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Bari Aldo Moro"
2019,31872372,"1573-3572","1068-9583","J Clin Psychol Med Settings","Journal of clinical psychology in medical settings","The Contribution of Illness Beliefs, Coping Strategies, and Social Support to Perceived Physical Health and Fatigue in Multiple Sclerosis.","10.1007/S10880-019-09692-6","1.893",0.9,"no_if_2015_found",1,0,0,,,"Y","Y","no_agenda",1.477,"University of Bari Aldo Moro"
2019,31176875,"1873-0183","1568-9972","Autoimmun Rev","Autoimmunity reviews","The gut microbiota perspective for interventions in MS.","10.1016/J.AUTREV.2019.03.016","8.745",8.961,"8.49",5,4,4,,,"Y","Y","no_agenda",7.716,"Institute of Genetic and Biomedical Research"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"University of Siena"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Associazione Italiana Sclerosi Multipla"
2019,30810827,"1590-3478","1590-1874","Neurol. Sci.","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.","10.1007/S10072-019-03780-Z","no_if_2017_found",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",,"Censis Foundation - Center for Social Studies"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Vanderbilt University Medical Center"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"National Institute of Health"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Catholic University of the Sacred Heart"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Catholic University of the Sacred Heart"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Don Carlo Gnocchi Foundation"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Istituto Neurologico Mediterraneo"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"Sapienza University of Rome"
2019,31379701,"1664-2295","1664-2295","Front Neurol","Frontiers in neurology","Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.","10.3389/FNEUR.2019.00695","3.508",3.552,"3.184",6,0,0,,,"Y","Y","progressive",2.635,"National Institute of Health"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Padua"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"Imperial College London"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31558148,"1471-2377","1471-2377","BMC Neurol","BMC neurology","Increase of CSF inflammatory profile in a case of highly active multiple sclerosis.","10.1186/S12883-019-1455-7","2.17",2.006,"1.961",11,0,0,,,"Y","Y","no_agenda",2.233,"University of Verona"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Catania"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Istituto Neurologico Mediterraneo"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Rome Tor Vergata"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Padua"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Ospedale Garibaldi"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"University of Liverpool"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Ospedale Garibaldi"
2019,31009904,"1872-8952","1388-2457","Clin Neurophysiol","Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","A pilot study on the efficacy of transcranial direct current stimulation applied to the pharyngeal motor cortex for dysphagia associated with brainstem involvement in multiple sclerosis.","10.1016/J.CLINPH.2019.04.003","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",,"Ospedale Garibaldi"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Associazione Italiana Sclerosi Multipla"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Multiple Sclerosis Society"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Siena"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Multiple Sclerosis Society"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Jan Kochanowski University"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Sydney"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Hospices Civils de Lyon"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Lyon Neuroscience Research Center"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Lyon System"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Belgrade"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Deutsche Multiple Sklerose Gesellschaft"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Karolinska Institute"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Ruhr University Bochum"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Karolinska Institute"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Bari Aldo Moro"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Karolinska Institute"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University Medical Center Göttingen"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Swansea University"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Haukeland University Hospital"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Bergen"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Aristotle University of Thessaloniki"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Aristotle University of Thessaloniki"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Hospital Universitari Vall d'Hebron"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Belgrade"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Arcispedale Sant'Anna"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Ferrara"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University Medical Center Göttingen"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Hospital Universitari Vall d'Hebron"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Turku"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Deutsche Multiple Sklerose Gesellschaft"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Karolinska Institute"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Bari Aldo Moro"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Hospices Civils de Lyon"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Lyon Neuroscience Research Center"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Lyon System"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Associazione Italiana Sclerosi Multipla"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Multiple Sclerosis Society"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Hospices Civils de Lyon"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"Lyon Neuroscience Research Center"
2019,30384204,"2211-0356","2211-0348","Mult Scler Relat Disord","Multiple sclerosis and related disorders","Multiple sclerosis registries in Europe - An updated mapping survey.","10.1016/J.MSARD.2018.09.032","3.199",2.349,"1.15",2,7,7,,,"Y","Y","no_agenda",2.725,"University of Lyon System"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"Spedali Civili di Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"University of Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"University of Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"Spedali Civili di Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"Spedali Civili di Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"National Institute of Allergy and Infectious Diseases"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"Spedali Civili di Brescia"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"University of Padua"
2019,31719595,"2045-2322","2045-2322","Sci Rep","Scientific reports","Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathy.","10.1038/S41598-019-53010-X","4.122",4.259,"5.228",1,0,0,,,"Y","Y","progressive",4.011,"Spedali Civili di Brescia"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"Ospedale San Luigi Gonzaga"
2019,31474999,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.","10.3389/FIMMU.2019.01935","5.511",6.429,"5.695",1,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,30565812,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.","10.1111/ENE.13875","4.621",3.988,"3.956",1,2,2,,,"Y","Y","no_agenda",4.387,"University of Turin"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"University of Siena"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"San Raffaele Hospital"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"Vita-Salute San Raffaele University"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"San Raffaele Hospital"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"Istituto Neurologico Mediterraneo"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"Sapienza University of Rome"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"San Raffaele Hospital"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"San Raffaele Hospital"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"Vita-Salute San Raffaele University"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"University of Campania Luigi Vanvitelli"
2019,31422457,"1432-1459","0340-5354","J. Neurol.","Journal of neurology","MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis.","10.1007/S00415-019-09509-4","3.783",3.389,"3.408",1,0,0,,,"Y","Y","no_agenda",4.204,"Associazione Italiana Sclerosi Multipla"
2019,28034466,"1872-8421","0165-5728","J. Neuroimmunol.","Journal of neuroimmunology","Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.","10.1016/J.JNEUROIM.2016.12.005","2.655",2.72,"2.536",1,13,12,,,"N","Y","progressive",2.832,"National Institute of Neurological Disorders and Stroke"
2019,28034466,"1872-8421","0165-5728","J. Neuroimmunol.","Journal of neuroimmunology","Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.","10.1016/J.JNEUROIM.2016.12.005","2.655",2.72,"2.536",1,13,12,,,"N","Y","progressive",2.832,"University of Cambridge"
2019,28034466,"1872-8421","0165-5728","J. Neuroimmunol.","Journal of neuroimmunology","Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.","10.1016/J.JNEUROIM.2016.12.005","2.655",2.72,"2.536",1,13,12,,,"N","Y","progressive",2.832,"University of Cambridge"
2019,28034466,"1872-8421","0165-5728","J. Neuroimmunol.","Journal of neuroimmunology","Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.","10.1016/J.JNEUROIM.2016.12.005","2.655",2.72,"2.536",1,13,12,,,"N","Y","progressive",2.832,"University of Cambridge"
2019,28034466,"1872-8421","0165-5728","J. Neuroimmunol.","Journal of neuroimmunology","Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.","10.1016/J.JNEUROIM.2016.12.005","2.655",2.72,"2.536",1,13,12,,,"N","Y","progressive",2.832,"University of Cambridge"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Sapienza University of Rome"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Sapienza University of Rome"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Sapienza University of Rome"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Pasteur Institute"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Sapienza University of Rome"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"University of Turin"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"University of Oxford"
2019,31068940,"1664-3224","1664-3224","Front Immunol","Frontiers in immunology","CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.","10.3389/FIMMU.2019.00864","5.511",6.429,"5.695",,2,2,,,"Y","Y","no_agenda",4.716,"Sapienza University of Rome"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Sapienza University of Rome"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Istituto Neurologico Mediterraneo"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Ospedale San Camillo"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Ospedale San Camillo"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Catholic University of the Sacred Heart"
2019,31167379,"2073-4409","2073-4409","Cells","Cells","Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.","10.3390/CELLS8060533","4.829",,"no_if_2015_found",,4,4,,,"Y","Y","no_agenda",5.656,"Fondazione Santa Lucia"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"Fondazione Santa Lucia"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"Institute Experimental Endocrinology and Oncology"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"Institute Experimental Endocrinology and Oncology"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"Imperial College London"
2019,31569668,"2076-3425","2076-3425","Brain Sci","Brain sciences","Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10.","10.3390/BRAINSCI9100259","no_if_2017_found",,"no_if_2015_found",,1,1,,,"Y","Y","no_agenda",2.786,"University of Naples Federico II"
2019,31805175,"1932-6203","1932-6203","PLoS ONE","PloS one","Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.","10.1371/JOURNAL.PONE.0226162","2.766",2.806,"3.057",9,0,0,,,"Y","Y","data_sharing",2.776,"University of Trieste"
2019,31805175,"1932-6203","1932-6203","PLoS ONE","PloS one","Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.","10.1371/JOURNAL.PONE.0226162","2.766",2.806,"3.057",9,0,0,,,"Y","Y","data_sharing",2.776,"University of Cagliari"
2019,31805175,"1932-6203","1932-6203","PLoS ONE","PloS one","Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.","10.1371/JOURNAL.PONE.0226162","2.766",2.806,"3.057",9,0,0,,,"Y","Y","data_sharing",2.776,"University of Trieste"
2019,31805175,"1932-6203","1932-6203","PLoS ONE","PloS one","Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.","10.1371/JOURNAL.PONE.0226162","2.766",2.806,"3.057",9,0,0,,,"Y","Y","data_sharing",2.776,"University of Trieste"
2019,31805175,"1932-6203","1932-6203","PLoS ONE","PloS one","Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.","10.1371/JOURNAL.PONE.0226162","2.766",2.806,"3.057",9,0,0,,,"Y","Y","data_sharing",2.776,"University of Trieste"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Alabama at Birmingham"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Catania"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"University of Cambridge"
2019,30905846,"2352-3964","2352-3964","EBioMedicine","EBioMedicine","SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke.","10.1016/J.EBIOM.2019.03.035","6.183",,"no_if_2015_found",7,3,3,,,"Y","Y","pediatric",6.68,"National Institute of Neurological Disorders and Stroke"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"University of Rome Tor Vergata"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Fondazione Santa Lucia"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Istituto Neurologico Mediterraneo"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"University of Rome Tor Vergata"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Campus Bio-Medico University"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Ospedale San Camillo"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Fondazione Santa Lucia"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Campus Bio-Medico University"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Fondazione Santa Lucia"
2019,31780628,"1592-8721","0390-6078","Haematologica","Haematologica","Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction.","10.3324/HAEMATOL.2019.219519","9.09",7.702,"6.671",1,2,2,,,"Y","Y","progressive",7.57,"Ospedale San Camillo"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Florence"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Genoa"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Genoa"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Siena"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Siena"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Genoa"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Genoa"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Siena"
2019,30133054,"1468-1331","1351-5101","Eur. J. Neurol.","European journal of neurology","Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.","10.1111/ENE.13789","4.621",3.988,"3.956",13,4,4,,,"Y","Y","no_agenda",4.387,"University of Genoa"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"National Research Council"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"Telethon Institute Of Genetics And Medicine"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"Telethon Institute Of Genetics And Medicine"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"SDN Istituto di Ricerca Diagnostica e Nucleare"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"Telethon Institute Of Genetics And Medicine"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"National Research Council"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"National Research Council"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"Telethon Institute Of Genetics And Medicine"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"University of Naples Federico II"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"MultiMedica"
2019,30862866,"2045-2322","2045-2322","Sci Rep","Scientific reports","Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis.","10.1038/S41598-018-38152-8","4.122",4.259,"5.228",1,0,0,,,"Y","Y","no_agenda",4.011,"Telethon Institute Of Genetics And Medicine"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Brescia"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Genoa"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Genoa"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Genoa"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Bari Aldo Moro"
2019,30870435,"1932-6203","1932-6203","PLoS ONE","PloS one","Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.","10.1371/JOURNAL.PONE.0213508","2.766",2.806,"3.057",1,3,3,,,"Y","Y","no_agenda",2.776,"University of Genoa"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"Istituto Neurologico Mediterraneo"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"University of Rome Tor Vergata"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"National Research Council"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"National Research Council"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"National Research Council"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"University of Naples Federico II"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"Fondazione Santa Lucia"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"National Research Council"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"University of Bari Aldo Moro"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"Istituto Neurologico Mediterraneo"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"Sapienza University of Rome"
2019,30692524,"2041-4889","no_issn_linking","Cell Death Dis","Cell death & disease","IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism.","10.1038/S41419-019-1336-4","5.638",5.965,"no_if_2015_found",2,4,4,,,"Y","Y","progressive",5.959,"University of Genoa"
2019,30084706,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Functional and structural plasticity following action observation training in multiple sclerosis.","10.1177/1352458518792771","no_if_2017_found",,"no_if_2015_found",3,4,4,,,"Y","Y","no_agenda",,
2019,30867274,"1526-632X","0028-3878","Neurology","Neurology","Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.","10.1212/WNL.0000000000007267","7.609",7.592,"8.166",6,5,5,,,"Y","Y","pediatric",8.689,
2019,31865757,"1745-9206","1742-3953","Chronic Illn","Chronic illness","What factors influence feeling competent as a parent with multiple sclerosis?","10.1177/1742395319895310","no_if_2017_found",,"no_if_2015_found",,0,0,,,"Y","Y","no_agenda",,
2019,29173009,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.","10.1177/1352458517743091","no_if_2017_found",,"no_if_2015_found",3,8,8,,,"Y","Y","no_agenda",,
2019,29303036,"1477-0970","1352-4585","Mult. Scler.","Multiple sclerosis (Houndmills, Basingstoke, England)","Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.","10.1177/1352458517750767","no_if_2017_found",,"no_if_2015_found",2,13,13,,,"Y","Y","no_agenda",,
2019,28917696,"1095-9572","1053-8119","Neuroimage","NeuroImage","Brain mapping in multiple sclerosis: Lessons learned about the human brain.","10.1016/J.NEUROIMAGE.2017.09.021","5.426",5.835,"5.463",3,20,20,,,"Y","Y","no_agenda",5.812,
2019,31604244,"1095-9203","0036-8075","Science","Science (New York, N.Y.)","Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.","10.1126/SCIENCE.AAV7188","no_if_2017_found",,"no_if_2015_found",329,34,34,,,"N","Y","no_agenda",,
2019,31251915,"1097-4172","0092-8674","Cell","Cell","Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.","10.1016/J.CELL.2019.06.016","31.398",30.41,"28.71",1,1,1,,,"N","Y","no_agenda",36.216,
